Table 2.
Postoperative outcomes.
| Group 1 (n= 22) | Group 2 (n= 98) | P-value | |
|---|---|---|---|
| New AF | 3 (13.64%) | 5 (5.1%) | 0.161 |
| PPM | 2 (9.09%) | 8 (8.16%) | >0.99 |
| Endocarditis | 0 | 3 (3.09%) | >0.99 |
| LV OTO | 1 (4.5%) | 0 | 0.183 |
| New renal impairment | 2 (9.09%) | 7 (7.14%) | 0.669 |
| Cerebral complications | 0.337 | ||
| TIA | 0 | 1 (1.03%) | |
| Hemorrhagic stroke | 1 (4.5%) | 0 | |
| Bleeding complications | 0.002 | ||
| Access-site bleeding | 4 (18.18%) | 7 (7.14%) | |
| GI bleeding | 2 (9.09%) | 0 | |
| Major vascular complications | 3 (13.64%) | 3 (3.09%) | 0.076 |
| ICU stay (days) | 1 (1-5) | 3.5 (2-6) | 0.013 |
| Hospital stay (days) | 4.5 (2-14) | 14 (8-28) | <0.001 |
| Hospital mortality | 2 (9.09%) | 7 (7.14%) | 0.669 |
Continuous data are presented as median (25th-75th) percentiles and categorical data are presented as numbers and percentages. AF=atrial fibrillation; GI=gastrointestinal; ICU=intensive care unit; LVOTO=left ventricular outflow tract obstruction; TIA=transient ischemic attack